Founded in 2007, Curetis AG is a German molecular diagnostics company that focuses on the development and commercialization of reliable, fast and cost-effective tools for diagnosing severe infectious diseases, i.e. pneumonia. Its fully integrated molecular diagnostic solution will enable ease-to-use multiparameter pathogen and antibiotic resistance detection in only a few hours, a process that today can take up to days. Curetis has recently closed a € 20 Mio. Series A financing round.

Web: www.curetis.com